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1. Introduction 
The 17&oestradiol dehydrogenase (EC 1.1.1.62) of 
the human placental cytosal [l-3] catalyses the reac- 
tion: 
Oestradiol + NAD(P)+ * oestrone + NAD(P)H + H+ 
This enzyme is a dimer (34 000 X 2). In each 
monomer, 6 cysteines are present, of which two are 
protected by the coenzyme NADP+ from the alkylating 
reagents inactivating the enzyme (N-ethyl maleimide, 
dithio-bis nitrobenzoic acid). The selective labelling of 
one of these residues has permitted the isolation of a 
hepadecapeptide which includes this residue and, thus, 
gives some initial information on the structure of the 
active site of this dehydrogenase (Nicolas [4] ). 
We have tried to obtain more information about this 
site, and especially about the substrate recognition 
site, by using an alkylating steroid: iodo- 16a acetoxy-3 
oestrone (IAE). IAE was chosen as a competitive in- 
hibitor of the enzyme (Ki = 1.2 X lop5 M); this in- 
hibitor can bind the enzyme irreversibly by covalent 
binding. Here we are reporting the results obtained 
with this affinity label. 
2. Experimental 
2.1. Synthesis of iodo-I 6a acetoxy-3 (6, 7-3H]oestrone 
This product was synthesized by Melle C. Reliaud 
in the laboratory, as follows: [6,7-3H]Oestrone 
(450 mg; 1.2 mCi/mM) is refluxed for 1 hr in 20 ml of 
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benzene and 4.5 ml of isopropenylacetate. 5 Drops of 
concentrated sulfuric acid are added and the mixture 
is distilled for 2 hr. The reaction products are chroma- 
tographed on a kieselgel column and 200 mg of diace- 
toxy-3,17-estratetraene-1,3,5,16 are eluted with a 
benzene-diethylether mixture (9: 1). This product is 
dissolved in 20 ml of dioxane and stirred under nitrogen 
at 65” for 20 min. N-Iodosuccinimide (150 mg) is 
added and the mixture is left for 3 hr at 65” under 
nitrogen. After cooling, 200 mg of potassium iodide 
and 250 mg of sodium thiosulfate dissolved in a 
minimum of water are added. The crude products 
(225 mg) are extracted with chloroform. The purifica- 
tion on a kieselgel column, eluted with a pentane- 
benzene gradient, gives 50 mg of pure iodo- 16o 
acetoxy-3 [6,7-3H]oestrone. The chemical purity of 
the product is controlled by thin-layer chromatography, 
IR spectrophotometry and melting point determination 
(F = 142-145”). 
The radiochemical purity, tested after thin-layer 
chromatography with a Panax scanner is more than 
98%. 
2.2. Buffers and reagents used 
Buffer A: 0.07 M phosphate buffer, 20% glycerol, 
pH 7.2. 
Buffer B: buffer A is brought to pH 8.8 with a 2 M 
Tris solution. 
Buffer C: buffer B + [6-7-3H] oestradiol (CEA) 
1 O-5 M, (2400 cpm/ml). 
Scintillation solution A; 400 mg PPO, 12 g POPOP 
in 4 P toluene-Triton X-100 (2: 1) mixture. 
Scintillation solution B: 7 g butyl PBD (Intertech- 
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niquej,, 20 g naphthalene (Merck), 700 ml dioxane, 
300 ml toluene (Prolabo). 
NADP, NADPH are from Boehringer Mannheim. 
2.3. Enzyme purification and protein determination 
The enzyme is purified by affinity chromatography 
according to [5 ] and rechromatographed on DEAE- 
cellulose just before the labelling. Its specific activity 
is 4 UI at the exit of the column (the enzyme is then 
in solution in buffer A). 
The protein concentration is determined by amino 
acid analysis: 2 ml of enzyme (300-500 pg) 
are precipitated by 3 ml of 10% trichloroacetic acid 
(TCA). The precipitate is filtered on a Whatman GF/A 
glass filter, washed twice with 5 ml of TCA (10%) and 
once with 5 ml of ethanol. The precipitate and the glass 
filter are dried and introduced into a sealed tube and 
the hydrolysis is performed under vacuum during 24, 
48 or 72 hr in 2 ml of 6 N hydrochloric acid. The 
hydrolysate is freeze dried and dissolved in 1 ml of 
0.2 M citrate buffer pH 2.2 in order to analyse the 
amino acids (Multichrom Beckman). 
2.4. Inhibition of the enzyme by iodo-I 6& acetoxy-3 
f 6, 7-3H]oestrone 
The inhibition experiments are performed at pH 8.8 
(buffer B) by addition of 40 or 100 ~1 of inhibitor 
solution (5 X 10d3 M in ethanol) to 10 ml of the 
enzyme solution (final cont. of the inhibitor: 2 or 
5 X 1O-5 M). We then incubate at 37” from 0 to 6 hr. 
We conjointly determine the kinetics of inactivation 
and the kinetics of irreversible binding of the inhibitor. 
The binding of the inhibitor to the protein is meas- 
ured by two different produres: 
2.4.1. Procedure 1 
1 ml of enzyme solution added to 1 ml of ethanol 
is precipitated at 0” by 3 ml of 10% TCA and washed 
according to 2.3. Then, the precipitate and the glass 
filter are dried and placed into a counting vial; the 
precipitate is dissolved with 1 ml of NCS (Nuclear 
Chicago) at 45” for I5 min, 15 ml of scintillation 
liquid A is added and the amount of radioactive in- 
hibitor bound is determined by counting in a Packard 
3320 spectrometer. 
2.4.2. Procedure 2 
The covalent labelling is stopped by addition of 
10 ~1 of &mercaptoethanol to 1 ml of the incubation 
medium described above (2.4). The mixture is dialysed 
4 times with 1 II of bidistilled water and once with 
50 ml of 5% glycerol solution in bidistilled water. The 
dialysis bag is totally dried at 110” during 120 min. 
The amount of inhibitor is determined after combus- 
tion of the dialysis bag in an “Oxymat Intertechnique” 
apparatus, by counting in the scintillation solution B. 
2.5. Attempt to protect the enzJ)me from inhibitor 
We have studied the protective effect either of the 
coenzyme (NADP) or of the substrate (oestradiol) or 
of both from the enzyme inactivation and from the 
binding of the inhibitor. The concentration of each of 
these protective agents is 1O-4 M. 
2.6. Enzyme-coenzyme binding 
Research for this enzyme-coenzyme binding was 
conducted, before and after inhibition, by fluorescence 
spectrometry (Velick [6], Jarabak [7], Mousseron [S]) 
and by measuring the fluorescence polarization factor 
by means of a spectrophotofluorimeter (Aminco 
Bowman) equipped with Glan polariser and analyser 
prisms. To 2 ml of native or inhibited enzyme (about 
160 pg), we add 5 ~1 aliquots of 0.24 mM NADPH 
in the same buffer. The fluorescence polarization is 
determined at 1.8 PM NADPH concentration. 
2.7. Enzyme-substrate binding 
The binding difference between inhibited and native 
enzyme is studied by filtration on a Biogel P-60 column 
(25 X 1 cm) (Jarabak [7]). The column is equilibrated 
with buffer C. 1 ml of enzyme solution is placed in the 
same buffer on the column. The radioactivity is meas- 
ured on a 50 ~1 aliquot of each fraction (1.5 ml) at the 
exit of the column, in 15 ml of scintillation liquid A. 
3. Results 
3.1. Enzyme concentration 
The analysis of amino acids of an enzyme solution 
(4 280 = 0.117, Acta III Beckman spectrophotometer) 
gave 160 mg of proteins/ml; the extinction coefficient 
of a freshly prepared enzyme solution is thus e% = 
0.73. This enzyme solution was used for all affinity 
labelling described below. 
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Fig. 1. Kinetics of enzyme inhibition by radioactive IAE (full lines -1 and of simultaneous irreversible binding of the inhibitor 
(dotted lines - - -1 expressed by N (N = moles of radioactive IAE linked/mole of enzyme). The experimental conditions are: in- 
cubation medium: buffer B; pH 8.8; t” = 37”. a) Unprotected enzyme (0); IAE = 5 X lo-’ M; b) unprotected enzyme (0); enzyme 
protected by the substrate oestradiol (+); IAE = 2 X lo-’ M; oestradiol = low4 M; cl enzyme protected by the coenzyme NADP 
(+l or by NADP + oestradiol (01; IAE = 2 X lo-’ M; NADP = low4 M; oestradiol = 10e4 M. 
3.2. Preliminary studies of inhibition conditions 3.3. Enzyme inactivation and irreversible binding of 
After a 4 hr incubation of the enzyme (2 X lo@ M) 
with 2 X low5 M IAE, the inactivation percentages at 
25” and three different pH’s (7.2, 8, 8.8) are, respec- 
tively, 3%, 5%, 30%; at 37” and pH 8.8 the inactivation 
percentage is 63%. 
Consequently, the following experiments are all 
conducted at 37” and at pH 8.8. Also, it was observed 
that, at pH 7.2, IAE can be reduced enzymatically 
without detectable inhibition during the time course 
of the measurement: V,,, = 68 moles of IAE reduced 
per mole of enzyme per min. 
the inhibitor with and without protection 
Fig. 1 shows the inactivation and irreversible bind- 
ing of IAE in the presence or in the absence of pro- 
tection: the enzyme is quickly inactivated by the in- 
hibitor in the absence of protection (fig. la). The 
binding velocity of IAE to enzyme is determined 
assuming that it is constant during the first 20 min: 
then for 2.3 nM of enzyme, 960 dpm are incorporated 
when the concentration of IAE = 2 X 1O-5 M, and 
1100 dpm when IAE = 5 X 10m5 M. This corresponds 
to, respectively, 0.008 and 0.009 M of inhibitor bound 
i 
PO- 
10: 
, 
0 0.6 1.2 1.8 3.0 42 (NADPH)(rM) 
Fig. 2. Fluorescence of NADPH (excitation 340 rim, emission 
450 nm). (-w 1 Buffer B (pH 8.8); ( t+-+) buffer B 
plus native enzyme; ( -) buffer B plus enzyme inhibited 
by IAE. p is the fluorescence polarisation coefficient for a 
NADPH concentration of 1.8 X 10d6 M. 
cpm 
I 
VO 
2 000 l 
1 3 5 7 (fractions) 
Fig. 3. Chromatography elution pattern of native enzyme (I) 
and of inactivated enzyme by non radioactive IAE (II) on a 
Biogel P.60 column equilibrated with tritiated oestradiol 
(2400 cpm/ml). The proteins are found in the fractions 2 and 3. 
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irreversibly per min per mole of enzyme. The substrate 
(fig. 1 b) or the coenzyme or their association (fig. 1 c) 
have an important protective effect against enzyme in- 
activation and against IAE irreversible binding. 
3.4. Enzyme-coenzyme binding 
Fig. 2 shows that the inhibited enzyme does not 
exalt the NADPH fluorescence (exaltation being 
characteristic of the formation of the enzyme-coen- 
zyme complex), when compared in the same way to 
the native enzyme. Furthermore, the NADPH fluore- 
scence polarisation in the presence of inhibited 
enzyme (p = 0.16) is very close to that of NADPH 
in buffer B (p = 0.14) and much smaller than that of 
NADPH in the presence of the native enzyme 
(p = 0.32). 
These two results clearly indicate that the inhibited 
enzyme does not bind to the coenzyme anymore. 
3.5. Enzyme-substrate binding 
Fig. 3 represents the filtration results on the Biogel 
P-60 column equilibrated with tritiated oestradiol: 
a) of a native enzyme sample (curve I); 
b) of an enzyme sample inactivated by the non 
radioactive inhibitor (curve II). 
The formation of the enzyme-substrate complex 
is evident in the case of native enzyme by an increase 
in the radioactivity eluted in the fractions containing 
the enzyme (fractions no. 2 and 3). There is a great 
decrease of binding in the case of inhibited enzyme. 
4. Discussion 
An inhibitor (I) is an enzyme affinity label when 
the irreversible inhibition follows the relationship 
(Baker [9] ): 
Et1 $ E...I 2 EI 
The following arguments show that this is the case 
with IAE and the 17P-oestradiol dehydrogenase: 
a) The formation of an intermediary complex E**.I 
is involved, since at a pH 7.2, the alkylation being im- 
possible, IAE is a substrate of the enzyme. Further- 
more, IAE is a competitive inhibitor in the oxidation 
of oestradiol to oestrone at pH 8.8 (Ki = 1.2 X 10p5). 
ACTIVITY 
t 
(%I 
Fig. 4. A plot of residual enzyme activity (%) against N (N = 
moles of radioactive IAE linked/mole of enzyme). 
b) The formation of this complex E...I is faster than 
the alkylation reaction since the minimum formation 
velocity limit of the Michaelis complex, measured by 
pax’ 
is quite superior to v2 (for 1 M of enzyme, 
max = 68 M X min-l and v2 = 0.009 M X min-‘). 
c) The substrate exhibits a protective effect against 
IAE and the inactivated enzyme loses the ability of 
binding the substrate. 
d) The kinetics of inactivation, at two different in- 
hibitor concentrations, permit the exclusion of the 
eventuality of a non specific bimolecular reaction. With 
such a reaction we should have: 
E t I + EI where v’ = k’(E) (I) and then, for 
(IAE)l = 5 X 10v5 M and (IAE), = 2 X lop5 M, the ratio 
v; 
- = 2.5. 
V; 
In fact, the experimental alkylation velocities ratio 
for these two concentrations is 0.009/0.008 = 1 .I 3. 
This value is incompatible with the preceding hypo- 
thesis but remains, on the contrary, compatible with 
the affinity labelling (Baker [9] ): in this case 
v2 = k(E...I) = k(E)(I)/(Ki +(I)) and this relationship 
gives 1.25 as a theoretical ratio of these two alkylation 
velocities. 
The affinity labelling shown by IAE possesses two 
particularities: 
i) The complete inactivation of the enzyme is experi- 
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mentally carried out only after the binding of 2 in- 
hibitor molecules to 1 enzyme molecule (fig. 4). How- 
ever, it is observed that the stoichiometry of inactiva- 
tion is, at first, l/l (curve A), then 2/l (curve B). This 
result suggests that the blocking of one out of two 
binding sites is sufficient to inactivate the dimer, 
without preventing the binding of a second inhibitor 
molecule. 
The determination of the binding site(s) of these 
inhibitor molecules is in progress by studying tryptic 
peptides. 
ii) The experiments on protections show that the 
substrate or the coenzyme protects the enzyme from 
inactivation and from binding of the inhibitor: this 
seems to indicate that the amino acids alkylated by 
the steroid belong to a zone where the substrate 
recognition site covers up the coenzyme recognition 
site. This hypothesis is supported by the fact that 
alkylation binds the steroid in a region which is near 
to that where the catalysed reaction occurs. 
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